| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/20/1999 | US5925378 Method for enhancing delivery and uniformity of concentration of cellular creatine |
| 07/20/1999 | US5925375 Therapeutic use of multilamellar liposomal prostaglandin formulations |
| 07/20/1999 | US5925374 Mixing anthelmintic benzimidazole with transdermal vehicle, mixing nonionic emulsifier with oil, blending mixturesin liquid phase, cooling, mixing with deflocculation agent/diluent mixture to provide microsuspension |
| 07/20/1999 | US5925373 Transdermal delivery device containing an estrogen |
| 07/20/1999 | US5925372 Mixed solvent mutually enhanced transdermal therapeutic system |
| 07/20/1999 | US5925364 Cosmetic or dermatological composition comprising an oil-in-water emulsion comprising oily globules with a lamellar liquid crystal coating |
| 07/20/1999 | US5925355 Preparations of Crataegus species, pharmaceutical compositions and their use for preventing sudden death due to cardiac arrest and reperfusion-caused cardiovascular lesions |
| 07/20/1999 | US5925350 Use of preparation comprising a plasminogen activator to improve wound healing |
| 07/20/1999 | US5925341 Nanoemulsion based on nonionic amphiphilic lipids and aminated silicones and uses |
| 07/20/1999 | US5925334 Administering phospholipid aersol as hyperosmolor compound, mucolytic agent or antisecretory agent |
| 07/20/1999 | US5925030 Orally administrable delivery device |
| 07/20/1999 | US5925015 Identifying with a dye, intravenous feeding |
| 07/20/1999 | CA2162919C Rectal compositions |
| 07/20/1999 | CA2060223C Injectable medical lubricating fluid composition and method of use |
| 07/20/1999 | CA1340660C Hydrophilic matrix dihydroergotamine (dhe) tablet and process for prducing the same |
| 07/20/1999 | CA1340656C Membrane anchor/active compound conjugate, its preparation and its use |
| 07/15/1999 | WO1999034941A1 Method for recovering medicaments from preparations, and from the precursors or wastes thereof |
| 07/15/1999 | WO1999034919A2 Device for coating granules to be administered orally |
| 07/15/1999 | WO1999034837A1 Stabilization of lipid:dna formulations during nebulization |
| 07/15/1999 | WO1999034835A1 Gene therapy of tumors using non-viral delivery system |
| 07/15/1999 | WO1999034832A1 Crystallographically stable amorphous cephalosporin compositions and process for producing the same |
| 07/15/1999 | WO1999034831A1 Enhanced transport using membrane disruptive agents |
| 07/15/1999 | WO1999034830A1 Topical ophthalmic preparations containing immunosuppressive agents |
| 07/15/1999 | WO1999034829A1 Embolizing compositions comprising surfactants |
| 07/15/1999 | WO1999034828A1 A transdermally administered pharmaceutical composition containing astringents |
| 07/15/1999 | WO1999034822A1 Formulations for amylin agonist peptides |
| 07/15/1999 | WO1999034816A1 Method for administering monomeric insulin analogs |
| 07/15/1999 | WO1999034815A1 Method for administering aspb28-human insulin |
| 07/15/1999 | WO1999034813A1 Supplement for dialysis patients |
| 07/15/1999 | WO1999034782A1 Tts containing an antioxidant |
| 07/15/1999 | WO1999034780A1 Method and device for capsulating active ingredients |
| 07/15/1999 | WO1999034779A1 Magnetically responsive composition |
| 07/15/1999 | WO1999034778A1 A method for making a pharmaceutical formulation |
| 07/15/1999 | WO1999034777A1 Liposomes containing multiple branch peptide constructions for use against human immunodeficiency virus |
| 07/15/1999 | WO1999034776A1 Nasal drop compositions |
| 07/15/1999 | WO1999034774A1 Topical application of enzymes using a peelable film |
| 07/15/1999 | WO1999034762A1 Container for an inhalation anesthetic |
| 07/15/1999 | WO1999034751A1 A drug dosage form based on the teorell-meyer gradient |
| 07/15/1999 | WO1999034694A1 Saccharide-based matrix comprising a maltodextrin, a gelling agent and a sugar |
| 07/15/1999 | WO1999034680A1 Decorated red blood cells |
| 07/15/1999 | WO1999024391B1 Radio-opaque polymer biomaterials |
| 07/15/1999 | WO1999024070A3 Ester derivatives of hyaluronic acid with viscoelastic properties and their use in the biomedical and healthcare field |
| 07/15/1999 | WO1999018884B1 Drug delivery system |
| 07/15/1999 | DE19900799A1 Material in contact with skin |
| 07/15/1999 | DE19800812A1 Effervescent oral composition containing L-arginine, as nutrient and for treating heart disease and hypercholesterolemia |
| 07/15/1999 | CA2365742A1 Formulations for amylin agonist peptides |
| 07/15/1999 | CA2321972A1 Gene therapy of tumors using non-viral delivery system |
| 07/15/1999 | CA2317739A1 Method for administering aspb28-human insulin |
| 07/15/1999 | CA2317733A1 Method for administering monomeric insulin analogs |
| 07/15/1999 | CA2317640A1 Decorated red blood cells |
| 07/15/1999 | CA2317010A1 Topical ophthalmic preparations containing immunosuppressive agents |
| 07/15/1999 | CA2316207A1 Saccharide-based matrix comprising a maltodextrin, a gelling agent and a sugar |
| 07/15/1999 | CA2315708A1 Stabilization of lipid:dna formulations during nebulization |
| 07/15/1999 | CA2256793A1 New compound intended by way of oromucous membrane notably pernasal |
| 07/14/1999 | EP0928616A1 Adsorbent carrier used in direct hemoperfusion and method for reducing the particle size thereof |
| 07/14/1999 | EP0928611A1 Medical powder |
| 07/14/1999 | EP0928610A1 Controlled release tacrine dosage form |
| 07/14/1999 | EP0928195A1 Compositions for use in embolizing blood vessels |
| 07/14/1999 | EP0928194A1 Compositions and methods for administering integrin receptor antagonists |
| 07/14/1999 | EP0928192A1 Antimycotic gel with high active substance release |
| 07/14/1999 | EP0928190A2 Nucleic acid particle delivery |
| 07/14/1999 | EP0928189A1 Delivery of biologically active material in a liposomal formulation for administration into the mouth |
| 07/14/1999 | EP0928188A1 Structures with double lipidic membranes or based on peptides |
| 07/14/1999 | EP0928187A1 Antibacterial composition |
| 07/14/1999 | EP0928135A1 System for enhancing cardiac signal sensing by cardiac pacemakers through genetic treatment |
| 07/14/1999 | EP0838084A4 Multilayer high vertical aspect ratio thin film structures |
| 07/14/1999 | EP0820772A4 Immunomodulating medicinal agent |
| 07/14/1999 | EP0804179B1 Use of n-acyl derivatives of aminoalcohols in the manufacture of a medicament for practising neuroprotective action in neuropathological states connected with excitotoxicity |
| 07/14/1999 | EP0735892B1 Laxative compositions containing bulk fiber and dioctyl sulfosuccinate |
| 07/14/1999 | EP0689422B1 Fluorocarbon emulsions with reduced pulmonary gas-trapping properties |
| 07/14/1999 | EP0619729B1 Composition to help stop smoking |
| 07/14/1999 | EP0581856B1 Method of preventing nmda receptor complex-mediated neuronal damage |
| 07/14/1999 | CN2328369Y Water-proof, air permeable bandages |
| 07/14/1999 | CN1222857A Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid |
| 07/14/1999 | CN1222403A Process for manufacture of amorphous products by means of convection drying |
| 07/14/1999 | CN1222387A Lotion for treating anal fistula and gynopathy |
| 07/14/1999 | CN1222382A Medicine bolus for hepatitis B and its preparation |
| 07/14/1999 | CN1222377A Hypertension ointment for external use |
| 07/14/1999 | CN1222368A Preparation of ointment for curing burns and scalds and promoting tissue generation |
| 07/14/1999 | CN1222363A Preparation of Chinese medicine for curing cardiac and cerebral diseases atomized by oxygen and its preparation process |
| 07/14/1999 | CN1222361A Zhongluo capsule as hair tonic |
| 07/14/1999 | CN1222347A Emulsion type nose spray |
| 07/14/1999 | CN1044093C Low-toxicity medicinal lipid preparation |
| 07/14/1999 | CN1044091C Chinese-medicinal capsule for treatment of psoriasis |
| 07/13/1999 | US5922841 Recombinantly produced transferrin receptor of haemophilus |
| 07/13/1999 | US5922766 Palatable elemental medical food |
| 07/13/1999 | US5922765 Methods and compositions for the prevention and treatment of muscle cramps and improving muscular strength |
| 07/13/1999 | US5922754 Pharmaceutical compositions containing paclitaxel |
| 07/13/1999 | US5922746 Inhibition of noninactivating Na channels of mammalian optic nerve as a means of preventing optic nerve degeneration associated with glaucoma |
| 07/13/1999 | US5922736 Chronic, bolus administration of D-threo methylphenidate |
| 07/13/1999 | US5922682 Polyol esters, their preparation and use in depot forms of pharmacologically active agents |
| 07/13/1999 | US5922580 Contacting a reducing partial starch hydrolysate with a novel enzyme which forms a non-reducing saccharide in the absence of trehalose; glucoamylase and glycosidase yield trehalose when allowed to act on the non-reducing saccharide |
| 07/13/1999 | US5922562 Nucleic acids encoding transferrin receptors |
| 07/13/1999 | US5922357 Polymer microspheres and a method of production thereof |
| 07/13/1999 | US5922356 Comprising collagen and glycosaminoglycan for controlling release |
| 07/13/1999 | US5922355 Composition and method of preparing microparticles of water-insoluble substances |
| 07/13/1999 | US5922354 Methods and system for processing dispersible fine powders |
| 07/13/1999 | US5922353 Interlocking couplings for osmotic delivery devices |
| 07/13/1999 | US5922352 Once daily calcium channel blocker tablet having a delayed release core |
| 07/13/1999 | US5922351 Compressed solid comprises a lubricating agent selected from potassium sorbate, calcium sorbate, a comicronized mixture of polyoxyethylene glycol with a coagent consisting of anhydrous trisodium citrate, calcium ascorbate and mixture |